STI
14
-17
ORCL
65
-2
INTU
56
-4
R
71
4
A
43
2
XYL
49
4
URI
65
5
LMT
34
2
XRX
44
3
DHI
48
4
UA
50
-9
UNP
52
7
GOOGL
40
-5
WY
54
4
CTSH
56
2
CMA
61
5
PGR
65
2
AN
58
4
SCHW
62
-2
MAS
58
2
STI
14
-17
ORCL
65
-2
INTU
56
-4
R
71
4
A
43
2
XYL
49
4
URI
65
5
LMT
34
2
XRX
44
3
DHI
48
4
UA
50
-9
UNP
52
7
GOOGL
40
-5
WY
54
4
CTSH
56
2
CMA
61
5
PGR
65
2
AN
58
4
SCHW
62
-2
MAS
58
2
Financhill
Back

Kazia Therapeutics Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
67

KZIA
Kazia Therapeutics

Last Price:
5.77
Seasonality Move:
17.72%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.

Kazia Therapeutics Price Quote

$5.77
+0.01 (+4.34%)
(Updated: November 23, 2024 at 5:42 AM ET)

Kazia Therapeutics Key Stats

Buy
67
Kazia Therapeutics (KZIA) is a Buy
Day range:
$5.57 - $5.97
52-week range:
$1.87 - $15.80
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
51.8K
Avg. volume:
173.1K
1-year change:
-17.71%
Market cap:
$25.1M
Revenue:
$1.5M
EPS:
$-6.67

How Much Does Kazia Therapeutics Make?

Data Unavailable

Is Kazia Therapeutics Growing As A Company?

  • What Is Kazia Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.96%
  • What Is Kazia Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Kazia Therapeutics Stock Price Performance

What Is Kazia Therapeutics 52-Week High & Low?

Kazia Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Kazia Therapeutics?

  • How Much Debt Does Kazia Therapeutics Have?
    Total long term debt quarterly is $423.8K
  • How Much Cash Does Kazia Therapeutics Have?
    Cash and short term investments quarterly total is $1.1M
  • What Is Kazia Therapeutics’s Book Value Per Share?
    Book value per share is -2.01

Is Kazia Therapeutics Cash Flow Positive?

  • What Is KZIA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$6.3M
  • What Is Kazia Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $3.9M
  • What Is Kazia Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Kazia Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    KZIA return on invested capital is -784.09%
  • What Is Kazia Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -106.28%
  • What Is KZIA Return On Equity?
    ROE is a measure of profitability and is -1083.16%

Kazia Therapeutics Earnings Date & Stock Price

Kazia Therapeutics Competitors

Kazia Therapeutics Dividend Yield

Kazia Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: -95.91% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 19.98
Upside from Last Price: 246.92%

Major Shareholders

  • How many KZIA shares are owned by institutional investors?
    5.1M KZIA shares are owned by institutional investors
  • How many KZIA shares are owned by insiders?
    19.8K KZIA shares are owned by insiders